We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
Check the tariff classification for peptide nisin standardised with sodium chloride
Guidance on prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
Check if you can get free NHS prescriptions, dental treatment or eye tests - or help with other NHS costs
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Oct - 31 Dec 2023.
Legal requirement for the sale of veterinary medicines on the internet and the VMD Accredited Internet Retailer Scheme (AIRS).
Complete this form to resume a prosecution when a patient becomes fit to plead.
An independent tribunal responsible for handling appeals against decisions made by the Secretary of State for Health and Social Care from pharmaceutical companies.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Information to support your recovery after COVID-19.
This series brings together all documents relating to Guidance and methods
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Applying for an individual domestic drugs licence to prescribe cocaine, diamorphine and dipipanone for the treatment of addiction.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Guidance for pharmacists on prescriptions issued in EU countries, Norway, Iceland, Liechtenstein and Switzerland.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.